Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Ligand-engineered biomimetic nanoparticles targeting the Achilles’ heel of NSCLC for synergistic photodynamic-immunotherapy
Qingjun Yang; Xiaoling Guan; Yinshan Lin; Qiuyun Liu; Juyan Wei; Siqi Yang; Jiaqi Tian; Songpei Li; Lingmin Zhang; Yingpeng LiShow moreShow less
1. School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China; 2. Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, ChinaShow moreShow less
Cannibalism-inspired biomimetic nanovesicles achieve boosted tumor targeting capacity via senescence-induced membrane remodeling
Liyuan Zheng; Shuxian Duan; Yingying Li; Hui Che; Yuran Liang; Xingding Zhang; Bihua Lin; Caihong Li; Junjie Deng; Xianxiu Qiu; Qunzhou Zhang; Lin Qi; Jincheng ZengShow moreShow less
1. Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, School of Medical Technology, Guangdong Medical University, Dongguan, China; 2. Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat- sen University, Shenzhen, China; 3. Joint Centre of Translational Medicine, Wenzhou Institute, University of Chinese Academy of Science, Wenzhou, China; 4. Department of Oral & Maxillofacial Surgery and Pharmacology, University of Pennsylvania School of Dental Medicine, Philadelphia, USA; 5. Guangxi Key Laboratory for Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, ChinaShow moreShow less
Asymmetric photothermal hydrogel patch for temporally programmed ferroptosis modulation and electrical stabilization after myocardial infarction
Haosong Xi; Yanwei Ji; Bin Gui; Haoyuan Hu; Bin Li; Bo Zheng; Muheremu Muhetaer; Zipeng Deng; Qing Deng; Shaoqing Lei; Hong Jiang; Qing Zhou; Zhongyuan XiaShow moreShow less
1. Cardiovascular Hospital, Cardiovascular Research Institute, Hubei Key Laboratory of Cardiology, Renmin Hospital of Wuhan University, Cardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan University, Wuhan, China; 2. Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China; 3. Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan, China; 4. Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China; 5. Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, ChinaShow moreShow less
An endogenous metabolite nanomedicine restores pulmonary neuroimmune homeostasis in septic lung injury
Xiaolin Liu; Xintong Lu; Jing Wang; Yue Chen; Jiaxin Yan; Jiarui Dou; Xuejing Duan; Jiayi Shen; Le Yang; Xiaobin Pang; Gaofei WeiShow moreShow less
1. Laboratory of Cellular Metabolism and Precision Therapeutics, School of Life Science and Technology, Northwestern Polytechnical University, Xi’an, China; 2. Research & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China; 3. Department of Anaesthesiology, Northwest Women’s and Children’s Hospital, Xi’an, China; 4. Department of Pharmacy, Tangdu Hospital, The Fourth Military Medical University, Xi’an, China; 5. State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng, ChinaShow moreShow less
Biomimetic glucose‑deprivation nanomedicine inducing ferroptosis and disulfidptosis for postoperative glioblastoma therapy
Xinyan Hao; Tiantian Tang; Pengcheng Sun; Xinying Liu; Dehua Liao; Mengen Guo; Hai Huang; Muyan Li; Ming Wang; Daxiong Xiang; Tianjiao Geng; Junyong WuShow moreShow less
1. Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China; 2. Institute of Clinical Pharmacy, Central South University, Changsha, China; 3. Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China; 4. Department of Pharmacy, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China; 5. Department of Neurosurgery, The Second Xiangya Hospital, Central South University, Changsha, China; 6. Department of Pharmacy, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7. College of Clinical Pharmacy, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 8. State Key Laboratory of Neurology and Oncology Drug Development, The Second Xiangya Hospital, Central South University, Changsha, ChinaShow moreShow less
Spatiotemporally programmed biomimetic liposome coordinates vascular and immune modulation in pulmonary arterial hypertension
Jingsong Cao; Yuanyuan Cheng; Yuhan Wang; Ting Pan; Qi He; Yuxin Ma; Jiong-Wei Wang; Yinsong Wang; Ying Yu; Yujun ShenShow moreShow less
1. Department of Pharmacology, Tianjin Key Laboratory of Inflammatory Biology, Center for Cardiovascular Diseases, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, State Key Laboratory of Experimental Hematology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China; 2. Department of Surgery, Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 3. Cardiovascular Research Institute, National University Heart Centre, Singapore, Singapore; 4. Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, International Joint Laboratory of Ocular Diseases (Ministry of Education), Tianjin Key Laboratory On Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, ChinaShow moreShow less
FAQ
How long does JOURNAL OF NANOBIOTECHNOLOGY take to review a manuscript?
As of 2026-11-18, CrushSCI has 20 complete review records for JOURNAL OF NANOBIOTECHNOLOGY. The fastest paper went from submission to acceptance in 37 days (Quaternary ammonium carbon dots for membrane perforation-immunity synergistic therapy against drug-resistant cancer metastasis, received 2026-06-04, accepted 2026-07-11); the slowest took 335 days. The average is 136.7 days and the median is 115.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
